Characterization of IgY for Oral Immunotherapy and Prevention of Pseudomonas aeruginosa Infections in Cystic Fibrosis Patients

Document -

Characterization of IgY for Oral Immunotherapy and Prevention of Pseudomonas aeruginosa Infections in Cystic Fibrosis Patients

Doctoral thesis, comprehensive summary. Elin Nilsson, 2009. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical Chemistry
  • License: Media Use
    The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
  • File format: .pdf
Download

Topics

  • Medical research

Contacts

Cari Hildebrand

Press contact +46 70 6057906

Related content

Drug candidate from hen’s eggs can replace antibiotics

Antibodies from hen’s eggs (IgY) may shortly come to revolutionize the treatment of patients suffering from the incurable disease cystic fibrosis. The European Commission has granted Swedish researchers over €5 million to ­conduct a clinical phase III study. The IgY-method, using antibodies from hen’s eggs, prevents infections and is also interesting as an alternative treatment to antibiotics.